AlphaYouRS
Insider selling
Robin Shane Readnour sold $97K of AN2 Therapeutics, Inc. (ANTX) stock
Robin Shane Readnour, Dir of AN2 Therapeutics, Inc. (ANTX), sold 16,119 shares of ANTX stock worth $97K, per an SEC Form 4 filed Sep 8, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 3, 2026, 5 days before it was made public.
ANTX has moved -16.6% since the trade date, from $5.95 to $4.96 (Sep 21, 2026 close).
- Traded
- Sep 3, 2026
- Disclosed
- Sep 8, 2026
- Filing delay
- 5 days
- Price since
- -16.6%
- Role
- Dir
- Source
- SEC Form 4
More ANTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.